Pinshan Biotech
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- $15M
Investors
- 4
About Pinshan Biotech
, trading as Pinshan Biotech, operates in the biotechnology sector, specifically targeting the biopharmaceutical industry. Pinshan Biotech specializes in the research, development, production, and sales of core consumables in the biotechnology and biopharmaceutical sectors. The company’s primary product offerings include essential tools for cell culture, filtration, and chromatographic purification, integral to the manufacturing processes of biopharmaceuticals. Their products enhance the efficiency and reliability of bioprocessing, addressing critical needs in the production of therapeutic agents such as monoclonal antibodies, gene therapies, and cell immunotherapies. Pinshan Biotech operates primarily through a B2B transaction model, providing high-quality biotechnology products directly to biopharmaceutical companies.
Who invested in Pinshan Biotech
4 investors across 1 round
See all investors in Pinshan Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 20, 2026
Amount
$15M
Investors
Questions about Pinshan Biotech
Who invested in Pinshan Biotech?
Pinshan Biotech has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pinshan Biotech raised?
Pinshan Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pinshan Biotech last raise money?
Pinshan Biotech's most recent round on record is a Series A, in Jul 2026.
What does Pinshan Biotech do?
, trading as Pinshan Biotech, operates in the biotechnology sector, specifically targeting the biopharmaceutical industry.
Where is Pinshan Biotech headquartered?
Pinshan Biotech is headquartered in Shanghai, China.
Which VCs invest in companies like Pinshan Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Pinshan Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pinshan Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.